Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
Saved in:
| Title: | Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer. |
|---|---|
| Authors: | Boers J; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Zwager MC; Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., den Dekker MAM; Department of Radiology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 Utrecht, The Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands., van Herpen CML; Department of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands., Menke-van der Houven van Oordt WC; Department of Medical Oncology, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Department of Medical Oncology, Dutch Cancer Institute, 1066 Amsterdam, The Netherlands. |
| Corporate Authors: | IMPACT-Metastatic Breast Consortium |
| Source: | Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Feb 14; Vol. 14 (4). Date of Electronic Publication: 2024 Feb 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2075-4418 |
|---|---|
| DOI: | 10.3390/diagnostics14040416 |
